Pulse Biosciences PLSE
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$608.8K (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 73.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 3.88% to 4.07% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +503,373 | 0.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +207,194 | 2.3% |
| Federated Hermes, Inc. | Mutual Fund | 2026/Q3 | +160,965 | 0.2% |
| TD Asset Management | Mutual Fund | 2026/Q3 | +154,066 | 0.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +149,310 | 1.3% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +61,042 | 0.3% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +39,342 | 0.1% |
| Columbia Management Investment Advisers, LLC | Mutual Fund | 2026/Q3 | +29,378 | 0.0% |
| Columbia Management Investment Advisers, LLC | Mutual Fund | 2026/Q3 | +31,990 | 0.0% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +46,627 | 0.1% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +733,779 | 1.0% |
| Bank of America Corporation | Public Company | 2026/Q3 | +580,550 | 2.0% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +484,364 | 0.9% |
| Balyasny Asset Management L.P. | Hedge Fund | 2026/Q3 | +452,939 | 1.0% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +240,712 | 0.4% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 31 Aug 2026 | Liane Teplitsky | Chief Operating Officer | Open Market Acquisition | +2,025 | $49.95 | 4,095 |
| 27 Aug 2026 | Liane Teplitsky | Chief Operating Officer | Open Market Acquisition | +2,070 | $48.35 | 2,070 |
| 7 Aug 2026 | Liane Teplitsky | Chief Operating Officer | Other Derivative Acquisition | +200,000 | – | 200,000 |
| 7 Aug 2026 | Liane Teplitsky | Chief Operating Officer | Other Derivative Acquisition | +700,000 | $19.06 | 700,000 |
| 10 Jun 2026 | Richard van den Broek | Independent Director | Other Derivative Acquisition | +38,423 | $26.89 | 8,423 |
| 10 Jun 2026 | Robert Duggan | Independent Co-Chairman | Other Derivative Acquisition | +42,495 | $26.89 | 12,495 |
| 10 Jun 2026 | Maria Degois-Sainz | Independent Director | Other Derivative Acquisition | +33,793 | $26.89 | 3,793 |
| 10 Jun 2026 | Mahkam Zanganeh | Independent Director | Other Derivative Acquisition | +44,504 | $26.89 | 14,504 |
| 10 Jun 2026 | Manmeet Soni | Lead Independent Director | Other Derivative Acquisition | +30,000 | $26.89 | 30,000 |
| 10 May 2026 | Paul LaViolette | President, CEO & Co-Chairman of the Board | Open Market Acquisition | +15,000 | $19.69 | 15,846 |
| 10 May 2026 | Robert Duggan | Independent Co-Chairman | Open Market Acquisition | +660,233 | $19.69 | 48,820,236 |
| 22 Mar 2026 | Darrin Uecker | CTO & Director | Other Derivative Acquisition | +100,000 | – | 100,000 |
| 17 Feb 2026 | Kevin Danahy | Former Chief Commercial Officer | Derivative Exercise and Sale | -5,000 | $23.64 | 43,298 |
| 16 Feb 2026 | Kevin Danahy | Former Chief Commercial Officer | Derivative Exercise and Sale | -60,000 | $23.63 | 43,298 |
| 11 Feb 2026 | Kevin Danahy | Former Chief Commercial Officer | Intent to Sell (Form 144) | -50,000 | $25.25 | – |
| 10 Feb 2026 | Kevin Danahy | Former Chief Commercial Officer | Derivative Exercise and Sale | -60,000 | $25.20 | 43,298 |
| 8 Feb 2026 | Kevin Danahy | Former Chief Commercial Officer | Intent to Sell (Form 144) | -75,000 | $20.75 | – |
| 4 Feb 2026 | Maria Degois-Sainz | Independent Director | Other Derivative Acquisition | +53,104 | $14.72 | 3,104 |
| 1 Oct 2025 | Kevin Danahy | Former Chief Commercial Officer | Derivative Exercise and Sale | -4,600 | $18.53 | 43,298 |
| 18 Sep 2025 | Kevin Danahy | Former Chief Commercial Officer | Derivative Exercise and Sale | -20,400 | $18.49 | 43,298 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 2,900,286 | 4.1% | 8.3 |
| 15 Oct 2026 | 3,004,624 | 4.2% | 7.2 |
| 30 Sep 2026 | 3,312,487 | 4.6% | 5.6 |
| 15 Sep 2026 | 3,139,674 | 4.4% | 3.9 |
| 31 Aug 2026 | 3,121,131 | 4.4% | 7.9 |
| 14 Aug 2026 | 2,765,732 | 3.9% | 6.4 |
No comments yet — be the first to weigh in on PLSE.
Sign in to join the discussion.